Hikma Pharmaceuticals PLC (LON: HIK)
1,845.00
-22.00 (-1.18%)
Jul 2, 2024, 4:37 PM GMT
Hikma Pharmaceuticals Market Cap
Hikma Pharmaceuticals has a market cap or net worth of 4.09 billion as of July 2, 2024.
Market Cap
4.09B
Enterprise Value
4.85B
Revenue
2.27B
Ranking
n/a
PE Ratio
27.37
Stock Price
1,845.00
Market Cap Chart
Since December 31, 2003, Hikma Pharmaceuticals's market cap has increased from 666.28M to 4.09B, an increase of 514.42%. That is a compound annual growth rate of 9.25%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 2, 2024 | 4.09B | 3.38% |
Dec 31, 2023 | 3.96B | 19.69% |
Dec 31, 2022 | 3.31B | -39.50% |
Dec 31, 2021 | 5.47B | -14.52% |
Dec 31, 2020 | 6.40B | 27.11% |
Dec 31, 2019 | 5.03B | 21.18% |
Dec 31, 2018 | 4.15B | 46.67% |
Dec 31, 2017 | 2.83B | -33.95% |
Dec 31, 2016 | 4.29B | -19.39% |
Dec 31, 2015 | 5.32B | 10.54% |
Dec 31, 2014 | 4.81B | 55.66% |
Dec 31, 2013 | 3.09B | 61.35% |
Dec 31, 2012 | 1.92B | 29.87% |
Dec 31, 2011 | 1.48B | -23.12% |
Dec 31, 2010 | 1.92B | 55.58% |
Dec 31, 2009 | 1.23B | 63.59% |
Dec 31, 2008 | 753.84M | -39.81% |
Dec 31, 2007 | 1.25B | 32.79% |
Dec 31, 2006 | 943.15M | 10.95% |
Dec 31, 2005 | 850.08M | 18.79% |
Dec 31, 2004 | 715.62M | 7.41% |
Dec 31, 2003 | 666.28M | 10.79% |
View and export this data all the way back to 2003.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca PLC | 187.36B |
GSK plc | 61.31B |
Haleon plc | 29.46B |
Smith & Nephew plc | 8.48B |
ConvaTec Group Plc | 4.80B |
Oxford Nanopore Technologies plc | 867.80M |
Animalcare Group plc | 138.86M |
Shell plc | 184.12B |